(N588K) in the pore forming region of the cardiac K r channel (KCNH2, HERG). The mutations dramatically increase IK r leading to heterogeneous abbreviation of action potential duration and refractoriness and rendering the channel relatively unresponsive to IK r blockers. Conclusion: Our data point to a novel genetic mechanism responsible for sudden death in children, infants and young adults. The mutation leads to a heterogeneous abbreviation of action potential duration and refractoriness, creating the substrate for reentrant arrhythmias. 9:30 a.m.
Background:β-blockers are widely used to prevent the lethal cardiac events that associate long QT syndrome (LQTS) especially in KCNQ1-related LQTS (LQT1) patients. Some LQT1 patients, however, are refractory to this therapy. Methods and Results: Eighteen symptomatic LQTS patients (12 families) were genetically diagnosed to have heterozygous KCNQ1 variants and received β-blocker therapy. Cardiac events recurred in 4 members (3 families) despite the continued therapy during the mean follow-up period of 70 months. Three of them (2 families) had the same mutation, A341V (KCNQ1), and the other had R243H (KCNQ1). The latter patient took aprindine that seemed to be responsible for the event. Because A341V (KCNQ1) has not been evaluated in heterologous mammalian expression system, we conducted functional analysis to investigate severe phenotype using COS7 cells. And we found that A341V (KCNQ1) is a loss-of-function type mutation (not dominant negative) as well as previous report in Xenopus oocytes. Further genetic screening revealed that one A341V (KCNQ1) family cosegregated with S706C (KCNH2) and another with G144S (KCNJ2). Produced functional outcome of S706C (KCNH2) mutation reduced current density with voltage shift of activation kinetics. Action potential simulation study was conducted based on the KYOTO model to estimate influences of additional gene modifiers. In both models mimicking LQT1 plus 2 and LQT1 plus 7, incidence of early afterdepolarization increased compared with LQT1 model under the setting of β adrenergic stimulation. Conclusion: Multiple mutations in different LQTS-related genes may modify the clinical characteristics. Expanded gene survey might be required in the LQT1 patients who are resistant to β-blocker therapy.
10:00 a.m. 10:15 a.m.
807-4 CUG Expansions in a Myotonic Dystrophy Mouse Model Cause Cardiac Conduction Abnormalities and Pathologic Electrophysiology Findings

807-5 Extracellular pH Modifies Drug Blockade on the Human Ether-A-Go-Go Related Gene (HERG) Channels
Lin Congrong, Ivana Cvetanovic, Vasant Ranade, John C. Somberg, Rush University, Chicago, IL Background: HERG encodes the rapid component of delayed rectifier potassium current (IKr), which is critical for the repolarization of cardiac action potentials. Significant change in pH can occur during ischemia and reperfusion, and the effects of pH on IKr could be an important underlying mechanism for arrhythmias. Methods: We investigated the effect of external pH on IKr, as well as the influence of external pH on the effect of IKr inhibition by anti-arrhythmia agents. HERG expressed in Xenopus oocytes was used as the experimental model. Results: Extracellular acidification decreased the amplitudes of both relatively small outward currents and the large tail outward currents, while the decay of tail current was accelerated. The steady state current was decreased by 14.4±6.8%, 19.8±10.4%, 23.8±10.4%, 28.3±10.5%, and the tail current was decreased by 6.7±1.1%, 8.7±2.1%, 13.4±1.5%, and 26.4±3.0% when decreasing pH from 8.0 to 7.4, 7.0, 6.6, and 6.2, respectively. The effect of acidification and IKr inhibition by quinidine, dofetilide, and azimilide was evaluated. There was no additive or synergistic effect between extracellular pH and antiarrhythmics on HERG. Quinidine 10 µM inhibited HERG tail current by 37.2±4.8% at pH 7.4. This inhibition was increased to 50.9±4.7% when extracellular pH was 8.0 and decreased to 4.5±1.8% when extracellular pH was 6. 
